1.45
price up icon1.40%   0.02
after-market 시간 외 거래: 1.45
loading
전일 마감가:
$1.43
열려 있는:
$1.43
하루 거래량:
4,210
Relative Volume:
0.41
시가총액:
$45.29M
수익:
-
순이익/손실:
-
주가수익비율:
-0.5755
EPS:
-2.5197
순현금흐름:
-
1주 성능:
+0.69%
1개월 성능:
-3.33%
6개월 성능:
-31.60%
1년 성능:
-56.98%
1일 변동 폭
Value
$1.43
$1.47
1주일 범위
Value
$1.41
$1.47
52주 변동 폭
Value
$1.10
$3.89

Adlai Nortye Ltd Adr Stock (ANL) Company Profile

Name
명칭
Adlai Nortye Ltd Adr
Name
전화
-
Name
주소
-
Name
직원
123
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
ANL's Discussions on Twitter

ANL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ANL
Adlai Nortye Ltd Adr
1.45 52.77M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Adlai Nortye Ltd Adr Stock (ANL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-02 다운그레이드 H.C. Wainwright Buy → Neutral
2024-09-04 개시 H.C. Wainwright Buy
2023-10-24 개시 Cantor Fitzgerald Overweight

Adlai Nortye Ltd Adr 주식(ANL)의 최신 뉴스

pulisher
Aug 01, 2025

AlphaTime Acquisition Corp Debt Equity Composite Units recovery potential after sell offFree Long Hold Safe Return Strategy - Newser

Aug 01, 2025
pulisher
Jul 30, 2025

Comparing Adlai Nortye Ltd. Depositary Receipt in custom built stock radarsDaily Upside Movement Prediction With Data - Newser

Jul 30, 2025
pulisher
Jul 25, 2025

Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX) and Gilead Sciences (GILD) - The Globe and Mail

Jul 25, 2025
pulisher
Jul 09, 2025

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail

Jul 09, 2025
pulisher
Jul 09, 2025

Adlai Nortye Ltd. Announces 2025 Share Incentive Plan and Board Changes - TipRanks

Jul 09, 2025
pulisher
Jul 06, 2025

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC), Lexaria Bioscience (LEXX) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 06, 2025
pulisher
Jun 27, 2025

Adlai Nortye (NASDAQ:ANL) Trading Down 5.5% – Here’s What Happened - Defense World

Jun 27, 2025
pulisher
Jun 24, 2025

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Capricor Therapeutics (CAPR) and Abbott Laboratories (ABT) - The Globe and Mail

Jun 24, 2025
pulisher
Jun 02, 2025

H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS By Investing.com - Investing.com South Africa

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. WAINWRIGHT CUTS ADLAI NORTYE STOCK RATING AFTER TRIAL RESULTS - Investing.com

Jun 02, 2025
pulisher
May 30, 2025

Adlai Nortye Discontinues Buparlisib Development After Phase III Trial Results - TipRanks

May 30, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline - Investing.com India

Apr 17, 2025
pulisher
Apr 17, 2025

ANL stock touches 52-week low at $1.71 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com India

Apr 07, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Adlai Nortye stock hits 52-week low at $1.85 amid sharp decline - Investing.com India

Mar 28, 2025
pulisher
Feb 14, 2025

Adlai Nortye Announces Change in Auditing Firm - TipRanks

Feb 14, 2025
pulisher
Oct 18, 2024

Adlai Nortye stock strengthened by oncology trial results, H.C. Wainwright keeps at Buy list - Investing.com India

Oct 18, 2024
pulisher
Sep 29, 2023

Adlai Nortye IPO gives old Novartis cancer drug new life - BioPharma Dive

Sep 29, 2023
pulisher
Sep 27, 2023

Adlai Nortye Announces 2.5M ADS IPO at $23/sh - Investing.com

Sep 27, 2023
pulisher
Aug 17, 2023

CRVO Stock Quote Price and Forecast - CNN

Aug 17, 2023

Adlai Nortye Ltd Adr (ANL) 재무 분석

Adlai Nortye Ltd Adr (ANL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
자본화:     |  볼륨(24시간):